Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

Insiders Menu
Roster
Transactions
Xilio Therapeutics, Inc.

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
08/16/2023Huber Martin H. Jr.PRESIDENT AND HEAD OF R&DGrantStock Option (right to buy)136.5k$2.79$380.2k 08/16/2023
08/16/2023Brennan Kevin M.SVP, FINANCE AND ACCOUNTINGGrantStock Option (right to buy)25k$2.79$69.6k 08/16/2023
08/16/2023Frankenfield Christopher JamesCOOGrantStock Option (right to buy)300k$2.79$835.5k 08/16/2023
08/16/2023Russo ReneCEOGrantStock Option (right to buy)700k$2.79$1.9M 08/16/2023
08/03/2023Frankenfield Christopher JamesCOOGrantStock Option (Right to Buy)150k$2.75$412.5k 08/03/2023
04/01/2023Brennan Kevin M.SVP, FINANCE AND ACCOUNTINGGrantStock Option (right to buy)55k$3.17$174.4k 04/01/2023
01/01/2023English Edward CPRINCIPAL ACCOUNTING OFFICERGrantStock Option (right to buy)24k$2.69$64.6k 01/01/2023
01/01/2023Russo ReneCEOGrantStock Option (right to buy)350k$2.69$941.5k 01/01/2023
01/01/2023Huber Martin H. Jr.PRESIDENT AND HEAD OF R&DGrantStock Option (right to buy)136.5k$2.69$367.2k 01/01/2023
09/15/2022Heyman Tomas J.DirectorGrantStock Option (right to buy)26.4k$3.15$83.2k 09/15/2022
06/15/2022ROSS ROBERT W.DirectorGrantStock Option (right to buy)26.4k$2.28$60.2k 06/15/2022
06/15/2022Xu YuanDirectorGrantStock Option (right to buy)13.2k$2.28$30.1k 06/15/2022
06/15/2022Huber Martin H. Jr.PRESIDENT AND HEAD OF R&DGrantStock Option (right to buy)20k$2.28$45.6k 06/15/2022
06/15/2022Ross Michael JayDirectorGrantStock Option (right to buy)13.2k$2.28$30.1k 06/15/2022
06/15/2022Clancy Paul JDirectorGrantStock Option (right to buy)13.2k$2.28$30.1k 06/15/2022
06/15/2022Huber Martin H. Jr.PRESIDENT AND HEAD OF R&DGrantStock Option (right to buy)20k$2.28$45.6k 06/15/2022
06/15/2022Bonstein SaraDirectorGrantStock Option (right to buy)13.2k$2.28$30.1k 06/15/2022
06/15/2022Rossi ChristinaDirectorGrantStock Option (right to buy)13.2k$2.28$30.1k 06/15/2022
02/22/2022Russo ReneCEOGrantStock Option (right to buy)150k$12.66$1.9M 02/22/2022
02/22/2022Huber Martin H. Jr.PRESIDENT AND HEAD OF R&DGrantStock Option (right to buy)65k$12.66$822.9k 02/22/2022
02/22/2022Giovine SalvatoreCFOGrantStock Option (right to buy)49.5k$12.66$626.7k 02/22/2022
01/04/2022Xu YuanDirectorGrantStock Option (right to buy)26.4k$15.92$420.3k 01/04/2022
12/22/2021Russo ReneCEOGrantStock Option (right to buy)100k$13.83$1.4M 12/22/2021
12/22/2021Russo ReneCEOGrantStock Option (right to buy)100k$13.83$1.4M 12/22/2021
12/10/2021Bain Capital Life Sciences Investors, LLC10% OwnerPurchaseCommon Stock21.8k$9.56$208.6kSee footnotes12/08/2021
12/10/2021Bain Capital Life Sciences Investors, LLC10% OwnerPurchaseCommon Stock3.2k$10.24$32.6kSee footnotes12/08/2021
12/09/2021Bain Capital Life Sciences Investors, LLC10% OwnerPurchaseCommon Stock4k$9.84$39.5kSee footnotes12/08/2021
12/08/2021Bain Capital Life Sciences Investors, LLC10% OwnerPurchaseCommon Stock13.5k$9.62$129.5kSee footnotes12/08/2021
10/26/2021FMR LLC ConversionCommon Stock789.5k$0.00$0F-Prime Capital Partners Healthcare Fund IV LP10/26/2021
10/26/2021FMR LLC ConversionCommon Stock686.5k$0.00$0F-Prime Capital Partners Healthcare Fund IV LP10/26/2021
10/26/2021FMR LLC ConversionCommon Stock28.7k$0.00$0F-Prime Capital Partners Healthcare Fund IV LP10/26/2021
10/26/2021FMR LLC ConversionCommon Stock372.2k$0.00$0Impresa Fund III Limited Partnership10/26/2021
10/26/2021FMR LLC ConversionCommon Stock4.5k$0.00$0F-Prime Capital Partners Healthcare Advisors Fund IV LP10/26/2021
10/26/2021FMR LLC ConversionSeries A Preferred Stock7.5M$0.00$0F-Prime Capital Partners Healthcare Fund IV LP10/26/2021
10/26/2021FMR LLC ConversionSeries A-1 Preferred Stock6.5M$0.00$0F-Prime Capital Partners Healthcare Fund IV LP10/26/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy